The impact of nutritional state on the duration of sputum positivity of Mycobacterium tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 11, 2015, Pages 1369-1375

  Hatsuda, K ^a   Takeuchi, M ^b   Ogata, K ^a   Sasaki, Y ^a   Kagawa, T ^a   Nakatsuji, H ^a   Ibaraki, M ^a   Sakaguchi, M ^a   Kurata, M ^b   Hayashi, S ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Body mass index; Glucose intolerance; White blood cells

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT; BIOLOGICAL MARKER;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GLUCOSE INTOLERANCE; HUMAN; LABORATORY TEST; LEUKOCYTE; LEUKOCYTE COUNT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NUTRITIONAL STATUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPUTUM ANALYSIS; SPUTUM CULTURE; SPUTUM SMEAR; UNIVARIATE ANALYSIS; VALIDATION STUDY; ADOLESCENT; AGED; ISOLATION AND PURIFICATION; JAPAN; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; SPUTUM; TUBERCULOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; GLUCOSE INTOLERANCE; HUMANS; ISONIAZID; JAPAN; LEUKOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NUTRITIONAL STATUS; RETROSPECTIVE STUDIES; RIFAMPIN; RISK FACTORS; SPUTUM; TUBERCULOSIS; YOUNG ADULT;

EID: 84945582511     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0963     Document Type: Article

References (29)

1. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013.
2. Ministry of Health, Labor and Welfare, Japan. Changes in number of newly registered tuberculosis patients, prevalence rate, and the number of deaths. Tokyo, Japan: Ministry of Health, Labor and Welfare, 2012. http://www.mhlw.go.jp/english/wp/wp-hw5/dl/23010226e.pdf Accessed July 2015.
3. Ministry of Health, Labor and Welfare, Japan. Number and incidence rate of newly registered tuberculosis patients by patient classification and age group. Tokyo, Japan: Ministry of Health, Labor and Welfare, 2010.
4. Ministry of Health, Labor and Welfare, Japan. Summary of the act regarding infectious disease prevention and medical care for the patients. Tokyo, Japan: Ministry of Health, Labor and Welfare, 1999. http://www.mhlw.go.jp/english/wp/wp-hw3/dl/2-083.pdf Accessed July 2015.
5. Omori M. [The present status of diagnosis and treatment of tuberculosis patients in Japan]. Tokyo, Japan: The Research Institute of Tuberculosis, Japan Anti-tuberculosis Association, 1998. www.jata.or.jp/rit/rj/07kinkyu.html Accessed July 2015. [Japanese]
6. Lönnroth K, Williams B G, Cegielski P, Dye C. A consistent loglinear relationship between tuberculosis incidence and body mass index. Int J Epidemiol 2009; 39: 149-155.
7. Dye C, Bourdin Trunz B, Lönnroth K, Roglic G, Williams B G. Nutrition, diabetes and tuberculosis in the epidemiological transition. PLOS ONE 2011; 6: e21161.
8. Hayashi S, Takeuchi M, Hatsuda K, et al. The impact of nutrition and glucose intolerance on the development of tuberculosis in Japan. Int J Tuberc Lung Dis 2014; 18: 84-89.
9. PednekarMS, Hakama M, Hebert J R, Gupta P C. Association of body mass index with all-cause and cause-specific mortality: findings from a prospective cohort study in Mumbai (Bombay), India. Int J Epidemiol 2008; 37: 524-535.
10. Akhtar M, Bretzel G, Boulahbal F. Technical guide. Sputum examination for tuberculosis by direct microscopy in lowincome countries. In: Management of tuberculosis: a guide for low-income countries. Paris, France: International Union Against Tuberculosis and Lung Disease, 2000: pp 14-15.
11. Taylor Z, Nolan CM, Blumberg HM. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep. 2005; 54: 1-81.
12. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
13. Ministry of Health Law, Japan. [Dietary reference intakes in Japan]. Tokyo, Japan: Ministry of Health Law, 2005. http://www.mhlw.go.jp/houdou/2004/11/h1122-2.html. Accessed July 2015. [Japanese].
14. World Health Organization Expert Committee. WHO Technical Report Series 854. Physical status: the use and interpretation of anthropometry. Geneva, Switzerland: WHO, 1995: pp 362-364.
15. Hernandez-Pando R, Orozco H, Aguilar D. Factors that deregulate the protective immune response in tuberculosis. Arch Immunol Ther Exp 2009; 57: 355-367.
16. Weinsier R L, Hunker E M, Krumdieck C L, Butterworth C E, Jr. Hospital malnutrition. A prospective evaluation of general medical patients during the course of hospitalization. Am J Clin Nutr 1979; 32: 418-426.
17. Kim D K, Kim H J, Kwon S Y, et al. Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis. Eur Respir J 2008; 32: 1031-1036.
18. Kim H J, Lee C H, Shin S, et al. The impact of nutritional deficit on mortality of in-patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2010; 14: 79-85.
19. Dooley K E, Tang T, Golub J E, Dorman S E, CroninW. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009; 80: 634-639.
20. Isanaka S, Mugusi F, Urassa W, et al. Iron deficiency and anemia predict mortality in patients with tuberculosis. J Nutr 2012; 142: 350-357.
21. Riley R L, Mills C C, Nyka W, et al. Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward, 1959. Am J Epidemiol 1995; 142: 3-14.
22. Alisjahbana B, Sahiratmadja E, Nelwan E J, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007; 45: 428-435.
23. Guler M, Unsal E, Dursun B, Aydln O, Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 2007; 61: 231-235.
24. BakerMA, Harries A D, Jeon C Y, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011; 9: 81.
25. Akazawa Y. Prevalence and incidence of diabetes mellitus by WHO criteria. Diabetes Res Clin Pract 1994; 24 (Suppl): S23 S27.
26. Ito C. Trends in the prevalence of diabetes mellitus among Hiroshima atomic bomb survivors. Diabetes Res Clin Pract 1994; 24 (Suppl): S29-S35.
27. Kuzuya T. Prevalence of diabetes mellitus in Japan compiled from literature. Diabetes Res Clin Pract 1994; 24 (Suppl): S15 S21.
28. Islam M M, Horibe H, Kobayashi F. Current trend in prevalence of diabetes mellitus in Japan, 1964-1992. J Epidemiol 1999; 9: 155-162.
29. Ministry of Health, Labor andWelfare, Japan. National Health and Nutrition Survey. Tokyo, Japan: Ministry of Health, Labor and Welfare, 2012. http://www.mhlw.go.jp/bunya/kenkou/kenkou-eiyou-chousa.html Accessed August 2015.